Halbert Hargrove Global Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1
Closed -$225 – 539
2026
Q2
$225 Buy
+1
New +$219 ﹤0.01% 638
2025
Q4
– Sell
-7
Closed -$923 – 564
2025
Q3
$923 Buy
+7
New +$840 ﹤0.01% 670

Other funds holding JAZZ

Halbert Hargrove Global Advisors's JAZZ Position: Q3 2026 in Review

Halbert Hargrove Global Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2026, closing a stake of 1 share — an estimated $225 sold.

Halbert Hargrove Global Advisors first reported a position in JAZZ in Q3 2025 and held it in 2 quarters. The position peaked at $923 in Q3 2025. 668 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Halbert Hargrove Global Advisors reported no remaining Jazz Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 1 Jazz Pharmaceuticals share in Q3 2026, an estimated $225.
  • Halbert Hargrove Global Advisors first reported a position in Jazz Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • Halbert Hargrove Global Advisors's Jazz Pharmaceuticals position peaked at $923 in Q3 2025.
  • 668 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.